Gabarone Tablet
NDC Package 74157-111-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Gabarone (gabapentin) tablets is gabapentin is used with other medications to prevent and control seizures. This formulation utilizes a tablet delivery system. Marketed by Ina Pharmaceutics Inc., this product is identified by NDC 74157-111 and is authorized under FDA application ANDA211313.

Identification & Billing

NDC Package Code
74157-111-90
Package Description
90 TABLET in 1 BOTTLE
Product Code
74157-111
11-Digit Billing Format
74157011190
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
90 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Gabarone
Non-Proprietary Name
Gabapentin
Substance Name
Gabapentin
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
GABAPENTIN 400 mg/1
Pharmacologic Class
Decreased Central Nervous System Disorganized Electrical Activity - [PE] (Physiologic Effect)
Usage Information
Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Regulatory & Marketing

Labeler Name
Ina Pharmaceutics Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA211313
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-23-2024
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 74157-111-90 identifies a specific commercial package of 90 tablet in 1 bottle of Gabarone, a human prescription drug labeled by Ina Pharmaceutics Inc.. This tablet is formulated for oral use and contains gabapentin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ina Pharmaceutics Inc. on December 23, 2024. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

How is this Ina Pharmaceutics Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 74157011190. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
74157-111-90
11-Digit CMS (5-4-2)
74157-0111-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.